Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media
More topics under "C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media" (918,689)
C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
C12N 11 - Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof (12,439)
C12N 13 - Treatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves (3,958)
C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
C12N 3 - Spore-forming or isolating processes (415)
C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
08/2012
08/15/2012EP1537187B1 Organic species that facilitate charge transfer to or from nanostructures
08/15/2012EP0833934B2 Packaging systems for human recombinant adenovirus to be used in gene therapy
08/14/2012US8242256 siRNA useful to supress expression of EIF-5A1
08/14/2012US8242255 Antisense oligonucleotides against cPLA2, compositions and uses thereof
08/14/2012US8241885 Engineered proteases for affinity purification and processing of fusion proteins
08/09/2012US20120202710 Methods and compositions for generation of germline human antibody genes
08/09/2012US20120201817 Methods of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular antagonist
08/08/2012EP2484687A2 Methods and compositions for seamless cloning of nucleic acid molecules
08/07/2012US8236546 Variant Humicola grisea CBH1.1
08/07/2012US8236293 Means and methods for nucleic acid delivery vehicle design and nucleic acid transfer
08/07/2012CA2524258C Carrier complexes comprising cationic peptides for delivering molecules to cells
08/02/2012US20120196372 Methods for Reducing Gluconoylation of Proteins
08/01/2012EP2481814A2 Compositions and methods for treating and diagnosing cancer
08/01/2012EP2481287A1 Human skin equivalents expressing exogenous polypeptides
08/01/2012CN102618605A Unnatural reactive amino acid genetic code additions
07/2012
07/26/2012US20120190705 Methods of inhibiting choroidal neovascularization
07/26/2012US20120190058 Method for evaluating cell populations
07/25/2012CN102605062A Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
07/25/2012CN102604957A Stabilized immunomodulatory oligonucleotides
07/25/2012CN101076598B Compositions of orthogonal glutamyl-tRNA and aminoacyl tRNA synthetase pairs and uses thereof
07/24/2012US8227230 Human lysosomal proteins from plant cell culture
07/24/2012US8227193 Compositions and methods for gene expression
07/24/2012US8227187 Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores
07/19/2012US20120183967 Method and Compositions for Detection and Enumeration of Genetic Variations
07/19/2012US20120183601 Compositions And Methods For Regulation Of Tumor Necrosis Factor-Alpha
07/18/2012EP1709059B1 Methods of designing, synthesizing, and propagating reference nucleic acids
07/18/2012EP1613725B1 Altered fad2 and fad3 genes in brassica and the molecular marker-assisted detection thereof
07/18/2012EP1470148B1 Double-stranded oligonucleotides
07/17/2012US8224580 Optimization of crossover points for directed evolution
07/17/2012US8222480 Hypertonic conditions for cell and oocyte enucleation
07/17/2012CA2500783C Microarrays having multiple oligonucleotides in single array features
07/12/2012US20120177638 Antibodies to vla-1
07/11/2012CN1922198B Genetically modified yeast species and fermenation processes using genetically modified yeast
07/11/2012CN102558352A Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
07/11/2012CN102552933A 蛋氨酸酶在抗蛋氨酸和抗高半胱氨酸的化学治疗中的应用 Methioninase used in chemotherapy anti-methionine and homocysteine ​​in the anti-
07/10/2012CA2477954C Means and methods for the production of adenovirus vectors
07/10/2012CA2194172C Neurturin and related growth factors
07/05/2012US20120172252 High Density Sequence Detection Methods
07/05/2012US20120171669 Assay and Compositions for Detection of Bacillus Anthracis Nucleic Acid
07/05/2012US20120171232 In vivo efficacy of ny-eso-1 plus adjuvant
07/04/2012CN102533910A Methods for expression and purification of immunotoxins
07/04/2012CN101065478B Compositions and methods for propagation of neural progenitor cells
07/03/2012US8212113 Corn plant Mon88017 and compositions and methods for detection thereof
07/03/2012CA2402593C Monoclonal antibodies to the human ldl receptor, their production and use
06/2012
06/27/2012EP1685235B1 Cell culture tool and method
06/27/2012CN1863552B Tyrosinase mutant and methods of use thereof
06/27/2012CN1842707B Prion protein binding materials and methods of use
06/27/2012CN102517360A Variant humicola grisea cbh1.1
06/26/2012US8207315 Expression vector comprising nucleotide sequence coding angiogenic factor (VG5Q protein) for use in identifying modulators which reduce tumor necrosis factor-like weak inducer of apoptosis (TWEAK) activity and treat or prevent cell proliferative disorders
06/26/2012US8206952 Methods for high fidelity production of long nucleic acid molecules
06/26/2012US8206919 Gene expression markers for breast cancer prognosis
06/26/2012US8206898 RNA exit channel: target and method for inhibition of bacterial RNA polymerase
06/21/2012US20120157522 B. Anthracis Prevention and Treatment: Mutant B. Anthracis Lacking Luxs Activity and Furanone Inhibition of Growth, AI-2 Quorum Sensing, and Toxin Production
06/20/2012CN101255419B P ef-tu expression units
06/20/2012CN101128475B Delta15 desaturases suitable for altering levels of polyunsaturated fatty acids in oilseed plants and oleaginous yeast
06/19/2012US8202724 Methods of controlling proliferation and differentiation of stem and progenitor cells
06/19/2012US8202704 Trichoderma genes
06/14/2012US20120149650 Diphtheria Toxin Variant
06/14/2012US20120149590 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore
06/14/2012US20120149069 Methods and compositions for seamless cloning of nucleic acid molecules
06/13/2012EP2463269A1 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
06/13/2012EP1490110B1 Anti-alpha v beta 6 antibodies
06/12/2012US8198411 Anti-mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancer
06/12/2012US8198078 Fucosyl transferase gene
06/07/2012US20120144505 Targeted and regional cellular ablation in zebrafish
06/07/2012US20120143512 Methods of selection, reporting and analysis of genetic markers using broad-based genetic profiling applications
06/07/2012US20120142031 Real time electronic cell sensing systems and applications for cell-based assays
06/06/2012EP2460786A1 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
06/06/2012EP2261374B1 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having Class I membrane fusogenic envelope proteins
06/06/2012EP1626979B1 Genetically modified yeast species and fermentation processes using genetically modified yeast
06/06/2012EP1618177B1 High mannose glucocerebrosidease and its production in plant culture
06/05/2012US8193326 Nucleotide sequences coding oncogenic polypeptides for use in generating vaccines to prevent and treat cell proliferative disorders; genetic vaccines
06/05/2012US8192348 Engineered blood vessels
06/05/2012CA2496182C Terminal phosphate blocked nucleoside polyphosphates
05/2012
05/31/2012US20120137385 Transcription factors
05/31/2012US20120135515 Methods for producing preparations of recombinant aav virions substantially free of empty capsids
05/31/2012US20120134926 Charge-dynamic polymers and delivery of anionic compounds
05/30/2012EP2457922A1 Altered FAD2 and FAD3 genes in brassica and the molecular marker-assisted detection thereof
05/30/2012EP2457587A1 Anitbodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
05/30/2012EP2457586A1 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
05/30/2012EP2457577A1 Diphtheria toxin variant
05/30/2012EP1495116B1 Saccharomyces cerevisiae yeast strain with improved phytase activity
05/30/2012CN1703238B Recombinant intracellular pathogen immunogenic compositions and methods for use
05/29/2012US8188062 Delivery of DNA or RNA via gap junctions from host cells to target cells and a cell-based delivery system for antisense or siRNA
05/29/2012CA2516022C Model for studying the role of genes in tumor resistance to chemotherapy
05/24/2012US20120129918 Modified oligonucleotides for telomerase inhibition
05/24/2012US20120129910 Inhibition of Apoptosis-Specific eIF-5A(elF-5A1") with Antisense Oligonucleotides and siRNA as Anti-Inflammatory Therapeutics
05/24/2012US20120129215 Compositions of Orthogonal Lysyl-tRNA and Aminoacyl-tRNA Synthetase Pairs and Uses Thereof
05/24/2012US20120128724 Systems and methods for treating human inflammatory and proliferative diseases and wounds, with fatty acid metabolism inhibitors and/or glycolytic inhibitors
05/24/2012US20120128627 Il-17 homologous polypeptides and therapeutic uses thereof
05/23/2012EP2455467A1 Double-stranded oligonucleotides
05/23/2012EP2455458A2 Covalent tethering of functional groups to proteins
05/23/2012EP2455457A2 Covalent tethering of functional groups to proteins
05/23/2012EP1412750B1 T1r2-t1r3 hetero-oligomeric sweet taste receptors and cell lines that express said receptors and use thereof for identification of sweet taste compounds
05/23/2012CN1894401B Terminally differentiated dopaminergic neurons derived from human embryonic stem cells
05/22/2012US8183011 Endoribonuclease; detection of nucleic acid sequence; gene expression; incubation; measurement splitting
05/17/2012US20120122111 Rna sequence-specific mediators of rna interference
05/16/2012CN1839205B Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
05/16/2012CN1575338B Bv8 nucleic acids and polypeptides with mitogenic activity
05/16/2012CN101255431B Corynebacterium glutamicum genes encoding metabolic pathway proteins
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 ... 100